X4 Pharmaceuticals XFOR
NASDAQ XFOR
$3.04 +0.02 (+0.66%)
As of: Oct 21, 2026 · 12:58 PM EDT

X4 Pharmaceuticals (XFOR) Receivables - Net (2020 - 2026)

Updated

X4 Pharmaceuticals (XFOR) recorded Receivables - Net of $2.05 million in Q2 2026, up 78.8% from $1.15 million a year earlier and up 83.9% from the prior quarter.

Analysis

X4 Pharmaceuticals (XFOR) Receivables - Net (2020 - 2026) Analysis & Trends

At the end of FY2025, X4 Pharmaceuticals reported Receivables - Net of $573,000, down 46.4% from FY2024.

  • Across earlier years, Receivables - Net came in at $1.07 million in FY2024.
  • The Q2 2026 figure is the highest quarterly Receivables - Net since Q1 2020.
  • Per Business Quant, the preceding three quarters came in at $1.11 million (Q1 2026), $573,000 (Q4 2025) and $891,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.62 Bn 1,103.20 Bn 19.71 Bn
2 Johnson & Johnson 616.94 Bn 535.47 Bn 17.26 Bn
3 AbbVie 501.32 Bn 474.43 Bn 12.70 Bn
4 Merck 367.44 Bn 321.82 Bn 12.21 Bn
5 Novartis Ag 298.20 Bn 262.19 Bn 11.24 Bn
6 Astrazeneca 261.78 Bn 235.47 Bn 12.86 Bn
7 Amgen 235.70 Bn 191.10 Bn 7.24 Bn
8 Gilead Sciences 190.88 Bn 165.07 Bn 6.22 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn
10 X4 Pharmaceuticals 384.09 Mn -314.60 Mn 7.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.05 Mn
Mar 31, 2026 1.11 Mn
Dec 31, 2025 573,000.00
Sep 30, 2025 891,000.00
Jun 30, 2025 1.15 Mn
Mar 31, 2025 509,000.00
Dec 31, 2024 1.07 Mn
Mar 31, 2020 3.00 Mn
API Access

X4 Pharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=XFOR&period=max&api_key=YOUR_API_KEY